Cubist Pharmaceuticals Inc Fourth Quarter Earnings Sneak Peek

Cubist Pharmaceuticals Inc (NASDAQ:CBST) will unveil its latest earnings tomorrow, Wednesday, January 23, 2013. Cubist Pharmaceuticals is focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Cubist Pharmaceuticals Inc Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 48 cents per share, a rise of more than fourfold from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 45 cents. Between one and three months ago, the average estimate was unchanged. It has risen during the last month. Analysts are projecting profit to rise by 44.5% versus last year to $1.98.

Past Earnings Performance: Last quarter, the company reported profit of 68 cents per share versus a mean estimate of net income of. The company has beaten estimates for the past three quarters.

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

A Look Back: In the third quarter, profit rose 66.4% to $40.3 million (55 cents a share) from $24.2 million (33 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 18.1% to $238.2 million from $201.7 million.

Here’s how Cubist Pharmaceuticals Inc traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week: